Last reviewed · How we verify
NCT00739947
Arthroscopic Surgical Outcome Study In Subjects With Rotator Cuff Tears
trial testing Observational study of the surgical outcome in Rotator Cuff in 162 participants. Completed in 5 July 2011.
5 July 2011
Quick facts
| Lead sponsor | Pfizer |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 162 |
| Start date | 13 October 2008 |
| Primary completion | 5 July 2011 |
| Estimated completion | 5 July 2011 |
| Sites | 37 locations across United States |
Drugs / interventions tested
- Observational study of the surgical outcome
Conditions studied
- Rotator Cuff — all drugs for Rotator Cuff →
- Arthroscopic Surgery — all drugs for Arthroscopic Surgery →
Sponsor
Pfizer — full company profile →
Who can join
Adults 21 to 75, any sex, with Rotator Cuff or Arthroscopic Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an observational study that involves subjects with full-thickness rotator cuff tears treated by means of arthroscopy surgical repair, also known as arthroscopic surgery. The primary objective of this study is to observe the timing and rate of tendon retear in those subjects.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
An Evaluation of the Rotator Cuff Repair Research Pipeline.
Checketts JX, Scott J, Gordon J, Jones J, et al · · 2018 · cited 9× · PMID 30480012 · DOI 10.1177/2325967118805731
Verify or expand the search:
- PubMed search for NCT00739947
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rotator Cuff
Currently open trials in the same condition.
- NCT07135375 — Postoperative Rotator Cuff Rehabilitation: Functional, Pain and Sleep Quality · NA · recruiting
Other Pfizer trials
Trials by the same sponsor.
- NCT04982848 — Korea Post Marketing Surveillance (PMS) Study of Talzenna® · not yet recruiting
- NCT06873191 — A Study to Learn More About Tukysa Once it is Out in the Korean Market · not yet recruiting
- NCT07497854 — A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea · not yet recruiting
- NCT06507904 — A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Anta · Phase 1 · not yet recruiting
- NCT06864585 — A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00739947 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pfizer
- Last refreshed: 16 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00739947.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing